Methodologies for the Determination of Blood Alpha1 Antitrypsin Levels: A Systematic Review
- PMID: 34768650
- PMCID: PMC8584727
- DOI: 10.3390/jcm10215132
Methodologies for the Determination of Blood Alpha1 Antitrypsin Levels: A Systematic Review
Abstract
Background: The study of hematic concentrations of alpha1 antitrypsin (AAT) is currently one step in the diagnosis of AAT deficiency. To try to clarify the relevance of the laboratory techniques, we carried out a systematic review of the literature.
Methods: Studies evaluating the quantification of AAT in peripheral blood were searched in PubMed in July 2021. The selection criteria included (1) any type of study design that included a quantification of AAT in peripheral blood; (2) studies written in English or Spanish; (3) studies evaluating human beings; and (4) studies involving adults.
Results: Out of 207 studies, the most frequently used techniques were nephelometry (43.9%), followed by ELISA (19.8%) and turbidimetry (13.5%). Altogether, 182 (87.9%) cases expressed their results in units of gram, while 16 (7.7%) articles expressed them in units of mole. Only 2.9% articles referred to the standard used, 43.5% articles indicated the commercial kit used, and 36.2% indicated the analyzer used.
Conclusions: The technical aspects of these determinations are not always reported in the literature. Journals should be attentive to these technical requirements and ensure that they are included in the works in which AAT is determined in order to ensure a correct interpretation of the study findings.
Keywords: alpha1-antitripsin; blood concentration; nephelometry; plasma; serum; turbidimetry.
Conflict of interest statement
J.L.L.-C. has received honoraria during the last 3 years for lecturing, scientific advice, participation in clinical studies, or writing for publications for (in alphabetical order): AstraZeneca, Boehringer Ingelheim, Chiesi, CSL Behring, Esteve, Ferrer, Gebro, GlaxoSmithKline, Grifols, Menarini, Megalabs, Novartis, and Rovi. F.D. has received honoraria during the last 3 years for lecturing and congress registration from CSL Behring and Grifols. The rest of the authors declare no conflict of interest.
Figures
Similar articles
-
Measuring of Alpha-1 Antitrypsin Concentration by Nephelometry or Turbidimetry.Methods Mol Biol. 2024;2750:123-133. doi: 10.1007/978-1-0716-3605-3_12. Methods Mol Biol. 2024. PMID: 38108973
-
Alpha1-Antitrypsin Deficiency: Transition of Care for the Child With AAT Deficiency into Adulthood.Curr Pediatr Rev. 2019;15(1):53-61. doi: 10.2174/1573396314666181113094517. Curr Pediatr Rev. 2019. PMID: 30421678 Free PMC article.
-
Measuring and Interpreting Serum AAT Concentration.Methods Mol Biol. 2017;1639:21-32. doi: 10.1007/978-1-4939-7163-3_3. Methods Mol Biol. 2017. PMID: 28752443
-
Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.Arch Bronconeumol. 2015 Apr;51(4):185-92. doi: 10.1016/j.arbres.2014.05.008. Epub 2014 Jul 12. Arch Bronconeumol. 2015. PMID: 25027067 English, Spanish.
-
Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.Ann Pharmacother. 2005 Nov;39(11):1861-9. doi: 10.1345/aph.1E061. Epub 2005 Oct 11. Ann Pharmacother. 2005. PMID: 16219903 Review.
Cited by
-
Association of A1AT With Poor Functional Outcome in Patients With Acute Ischemic Stroke.J Am Heart Assoc. 2025 May 6;14(9):e036727. doi: 10.1161/JAHA.124.036727. Epub 2025 Apr 17. J Am Heart Assoc. 2025. PMID: 40247624 Free PMC article.
-
Measuring of Alpha-1 Antitrypsin Concentration by Nephelometry or Turbidimetry.Methods Mol Biol. 2024;2750:123-133. doi: 10.1007/978-1-0716-3605-3_12. Methods Mol Biol. 2024. PMID: 38108973
-
Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions.J Clin Med. 2023 Oct 12;12(20):6490. doi: 10.3390/jcm12206490. J Clin Med. 2023. PMID: 37892629 Free PMC article.
-
Bioanalytical Method Validations of Three Alpha1-Antitrypsin Measurement Methods Required for Clinical Sample Analysis.Pharmaceuticals (Basel). 2025 Aug 6;18(8):1165. doi: 10.3390/ph18081165. Pharmaceuticals (Basel). 2025. PMID: 40872556 Free PMC article.
-
Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency.Int J Mol Sci. 2022 Aug 30;23(17):9859. doi: 10.3390/ijms23179859. Int J Mol Sci. 2022. PMID: 36077263 Free PMC article.
References
-
- Torres-Durán M., Lopez-Campos J.L., Barrecheguren M., Miravitlles M., Martinez-Delgado B., Castillo S., Escribano A., Baloira A., Navarro-Garcia M.M., Pellicer D., et al. Alpha-1 antitrypsin deficiency: Outstanding questions and future directions. Orphanet J. Rare Dis. 2018;13:1–15. doi: 10.1186/s13023-018-0856-9. - DOI - PMC - PubMed
-
- Lopez-Campos J.L., Casas-Maldonado F., Torres-Duran M., Medina-Gonzálvez A., Rodriguez-Fidalgo M.L., Carrascosa I., Calle M., Osaba L., Rapun N., Drobnic E., et al. Results of a Diagnostic Procedure Based on Multiplex Technology on Dried Blood Spots and Buccal Swabs for Subjects with Suspected Alpha1 Antitrypsin Deficiency. Arch. Bronconeumol. 2021;57:42–50. doi: 10.1016/j.arbres.2020.04.014. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous